|
1
|
Kanavos P: The rising burden of cancer in
the developing world. Ann Oncol. 17 Suppl 8:viii15–viii23. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Reeler A, Qiao Y, Dare L, Li J, Zhang AL
and Saba J: Women's cancers in developing countries: From research
to an integrated health systems approach. Asian Pac J Cancer Prev.
10:519–526. 2009.PubMed/NCBI
|
|
3
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sharma V, Kerr SH, Kawar Z and Kerr DJ:
Challenges of cancer control in developing countries: Current
status and future perspective. Future Oncol. 7:1213–1222. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li Z, Lei H, Luo M, Wang Y, Dong L, Ma Y,
Liu C, Song W, Wang F, Zhang J, et al: DNA methylation
downregulated mir-10b acts as a tumor suppressor in gastric cancer.
Gastric Cancer. 18:43–54. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xiao X, Tang C, Xiao S, Fu C and Yu P:
Enhancement of proliferation and invasion by MicroRNA-590-5p via
targeting PBRM1 in clear cell renal carcinoma cells. Oncol Res.
20:537–544. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yin WZ, Li F, Zhang L, Ren XP, Zhang N and
Wen JF: Down-regulation of microRNA-205 promotes gastric cancer
cell proliferation. Eur Rev Med Pharmacol Sci. 18:1027–1032.
2014.PubMed/NCBI
|
|
8
|
Yang X, Ni W and Lei K: miR-200b
suppresses cell growth, migration and invasion by targeting Notch1
in nasopharyngeal carcinoma. Cell Physiol Biochem. 32:1288–1298.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu Z, Mai C, Yang H, Zhen Y, Yu X, Hua S,
Wu Q, Jiang Q, Zhang Y, Song X and Fang W: Candidate tumour
suppressor CCDC19 regulates miR-184 direct targeting of C-Myc
thereby suppressing cell growth in non-small cell lung cancers. J
Cell Mol Med. 18:1667–1679. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang Q, Wang Y, Lu X, Zhao Z, Zhu L, Chen
S, Wu Q, Chen C and Wang Z: MiR-125b regulates
epithelial-mesenchymal transition via targeting Sema4C in
paclitaxel-resistant breast cancer cells. Oncotarget. 6:3268–3279.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gong B, Hu H, Chen J, Cao S, Yu J, Xue J,
Chen F, Cai Y, He H and Zhang L: Caprin-1 is a novel microRNA-223
target for regulating the proliferation and invasion of human
breast cancer cells. Biomed Pharmacother. 67:629–636. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang J, Raimondo M, Guha S, Chen J, Diao
L, Dong X, Wallace MB, Killary AM, Frazier ML, Woodward TA, et al:
Circulating microRNAs in pancreatic juice as candidate biomarkers
of pancreatic cancer. J Cancer. 5:696–705. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Duan HF, Li XQ, Hu HY, Li YC, Cai Z, Mei
XS, Yu P, Nie LP, Zhang W, Yu ZD and Nie GH: Functional elucidation
of miR-494 in the tumorigenesis of nasopharyngeal carcinoma. Tumour
Biol. 36:6679–6689. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lu J, He ML, Wang L, Chen Y, Liu X, Dong
Q, Chen YC, Peng Y, Yao KT, Kung HF and Li XP: MiR-26a inhibits
cell growth and tumorigenesis of nasopharyngeal carcinoma through
repression of EZH2. Cancer Res. 71:225–233. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zheng W, Liu Z, Zhang W and Hu X: miR-31
functions as an oncogene in cervical cancer. Arch Gynecol Obstet.
292:1083–1089. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Song X, Shi B, Huang K and Zhang W:
miR-133a inhibits cervical cancer growth by targeting EGFR. Oncol
Rep. 34:1573–1580. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chang TC, Yu D, Lee YS, Wentzel EA, Arking
DE, West KM, Dang CV, Thomas-Tikhonenko A and Mendell JT:
Widespread microRNA repression by Myc contributes to tumorigenesis.
Nat Genet. 40:43–50. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang Q, Tang Q, Qin D, Yu L, Huang R, Lv
G, Zou Z, Jiang XC, Zou C, Liu W, et al: Role of microRNA 30a
targeting insulin receptor substrate 2 in colorectal tumorigenesis.
Mol Cell Biol. 35:988–1000. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Visone R, Pallante P, Vecchione A,
Cirombella R, Ferracin M, Ferraro A, Volinia S, Coluzzi S, Leone V,
Borbone E, et al: Specific microRNAs are downregulated in human
thyroid anaplastic carcinomas. Oncogene. 26:7590–7595. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li X, Zhang Y, Zhang Y, Ding J, Wu K and
Fan D: Survival prediction of gastric cancer by a seven-microRNA
signature. Gut. 59:579–585. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cheng CW, Wang HW, Chang CW, Chu HW, Chen
CY, Yu JC, Chao JI, Liu HF, Ding SL and Shen CY: MicroRNA-30a
inhibits cell migration and invasion by downregulating vimentin
expression and is a potential prognostic marker in breast cancer.
Breast Cancer Res Treat. 134:1081–1093. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang C and Pan Y: Fluorouracil induces
autophagy-related gastric carcinoma cell death through Beclin-1
upregulation by miR-30 suppression. Tumour Biol. Jul 25–2015.(Epub
ahead of print).
|
|
23
|
Kumarswamy R, Mudduluru G, Ceppi P,
Muppala S, Kozlowski M, Niklinski J, Papotti M and Allgayer H:
MicroRNA-30a inhibits epithelial-to-mesenchymal transition by
targeting Snai1 and is downregulated in non-small cell lung cancer.
Int J Cancer. 130:2044–2053. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang Q, Yu L, Qin D, Huang R, Jiang X,
Zou C, Tang Q, Chen Y, Wang G, Wang X and Gao X: Role of
microRNA-30c targeting ADAM19 in colorectal cancer. PLoS One.
10:e01206982015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu H, Sun H, Bai Y, Han J, Liu G, Liu Y
and Zhang N: MEF2D overexpression contributes to the progression of
osteosarcoma. Gene. 563:130–135. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Song L, Li D, Zhao Y, Gu Y, Zhao D, Li X,
Bai X, Sun Y, Zhang X, Sun H, et al: miR-218 suppressed the growth
of lung carcinoma by reducing MEF2D expression. Tumour Biol.
37:2891–2900. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Han K, Zhao T, Chen X, Bian N, Yang T, Ma
Q, Cai C, Fan Q, Zhou Y and Ma B: microRNA-194 suppresses
osteosarcoma cell proliferation and metastasis in vitro and in vivo
by targeting CDH2 and IGF1R. Int J Oncol. 45:1437–1449. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xu JQ, Zhang WB, Wan R and Yang YQ:
MicroRNA-32 inhibits osteosarcoma cell proliferation and invasion
by targeting Sox9. Tumour Biol. 35:9847–9853. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pon JR and Marra MA: MEF2 transcription
factors: Developmental regulators and emerging cancer genes.
Oncotarget. 7:2297–2312. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ma L, Liu J, Liu L, Duan G, Wang Q, Xu Y,
Xia F, Shan J, Shen J, Yang Z, et al: Overexpression of the
transcription factor MEF2D in hepatocellular carcinoma sustains
malignant character by suppressing G2-M transition genes. Cancer
Res. 74:1452–1462. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang M, Truscott J and Davie J: Loss of
MEF2D expression inhibits differentiation and contributes to
oncogenesis in rhabdomyosarcoma cells. Mol Cancer. 12:1502013.
View Article : Google Scholar : PubMed/NCBI
|
